Prime Medicine (NasdaqGM:PRME) FY Conference Transcript

Prime Medicine (NasdaqGM:PRME) FY Conference January 14, 2026 12:00 PM ET Company ParticipantsAllan Reine - CFOConference Call ParticipantsTessa Romero - VP and Biotech Equity Research AnalystTessa RomeroWelcome, everyone, to the 44th Annual J.P. Morgan Healthcare Conference. My name is Tess Romero, and I'm one of the Senior Biotech Analysts here at J.P. Morgan. Our next presenting company is Prime Medicine, and presenting on behalf of the company, we have CEO Allan Reine. Allan, over to you.Allan ReineThan ...